Evidence map›Paper›PMID 36353363›Full record

ArticleSTAR protocols2022

Protocol for large scale whole blood immune monitoring by mass cytometry and Cyto Quality Pipeline.

Paulina Rybakowska, Sofie Van Gassen, Jordi Martorell Marugán, Katrien Quintelier, Yvan Saeys, Marta E Alarcón-Riquelme, Concepción Marañón

Abstract read
In one paragraph

Article in STAR protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paulina RybakowskaGENYO, Centre for Genomics and Oncological Research Pfizer/University of Granada/ Andalusian Regional Government, PTS, 18016 Granada, Spain. Electronic address: paulina.rybakowska@genyo.es.
Sofie Van GassenDepartment of Applied Mathematics, Computer Sciences and Statistics, Ghent University, 9000 Gent, Belgium; Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, 9000 Gent, Belgium.
Jordi Martorell MarugánGENYO, Centre for Genomics and Oncological Research Pfizer/University of Granada/ Andalusian Regional Government, PTS, 18016 Granada, Spain; Department of Statistics and Operational Research, University of Granada, 18071 Granada, Spain; Data Science for Health Research Unit, Fondazione Bruno Kessler, 38123 Trento, Italy.
Katrien QuintelierDepartment of Applied Mathematics, Computer Sciences and Statistics, Ghent University, 9000 Gent, Belgium; Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, 9000 Gent, Belgium; Department of Pulmonary Diseases, Erasmus MC, 3015 Rotterdam, the Netherlands.
Yvan SaeysDepartment of Applied Mathematics, Computer Sciences and Statistics, Ghent University, 9000 Gent, Belgium; Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, 9000 Gent, Belgium.
Marta E Alarcón-RiquelmeGENYO, Centre for Genomics and Oncological Research Pfizer/University of Granada/ Andalusian Regional Government, PTS, 18016 Granada, Spain; Institute for Environmental Medicine, Karolinska Institute, 17177 Stockholm, Sweden.
Concepción MarañónGENYO, Centre for Genomics and Oncological Research Pfizer/University of Granada/ Andalusian Regional Government, PTS, 18016 Granada, Spain. Electronic address: concepcion.maranon@genyo.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mass cytometry (MC) is a powerful large-scale immune monitoring technology. To maximize MC data quality, we present a protocol for whole blood analysis together with an R package, Cyto Quality Pipeline (CytoQP), which minimizes the experimental artifacts and batch effects to ensure data reproducibility. We describe the steps to stimulate, fix, and freeze blood samples before acquisition to make them suitable for retrospective studies. We then detail the use of barcoding and reference samples to facilitate multicenter and multi-batch experiments. For complete details on the use and execution of this protocol, please refer to Rybakowska et al. (2021a) and (2021b).

Indexed as

Leukocytes, MononuclearFlow CytometryMonitoring, ImmunologicMulticenter Studies as TopicReproducibility of ResultsRetrospective StudiesClinical protocolFlow cytometry/Mass cytometryImmunology

Identifiers

PMID36353363
PMCPMC9637821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.